Start Over Please hold this item Export MARC Display Return To Browse
 
     
Record: Previous Record Next Record
Title Communicable disease control and health protection handbook / Jeremy Hawker ... [et al.].
Related title Communicable disease control handbook.
Publication Info Chichester : Wiley-Blackwell, 2012.
Edition 3rd ed.



Descript xiii, 440 p. : col. ill.
Edition 3rd ed.
Note Previous ed.: published as Communicable disease control handbook. Blackwell Science, 2005.
Contents Foreword. Abbreviations. Section 1: Introduction. 1.1 How to use this book. 1.2 Basic Concepts in the Epidemiology and Control of InfectiousDisease. 1.3 Health Protection on-call. Section 2: Common topics. 2.1 Meningitis and meningism. 2.2 Gastrointestinal infection. 2.3 Community acquired pneumonia. 2.4 Rash in pregnancy. 2.5 Rash and fever in children. 2.6 Illness in returning travellers. 2.7 Sexually Transmitted Infections. 2.8 Jaundice. 2.9 Infection in the immunocompromised. 2.10 Blood borne viral infections. 2.11 Vaccine Queries. 2.12 Individual measures against infections. Section 3: Diseases. 3.1 Amoebic dysentery. 3.2 Anthrax. 3.3 Bacillus cereus. 3.4 Botulism. 3.5 Brucellosis. 3.6 Burkholderia. 3.7 Campylobacter. 3.8 Chickenpox and shingles (varicella-zoster infections). 3.9 Chikungunya. 3.10 Chlamydophila pneumoniae. 3.11 Chlamydophila psittaci. 3.12 Chlamydia trachomatis (genital). 3.13 Cholera. 3.14 CJD and other human transmissible spongiformencephalopathies. 3.15 Clostridium difficile. 3.16 Clostridium perfringens. 3.17 Coxsackievirus infections. 3.18 Cryptosporidiosis. 3.19 Cyclosporiasis. 3.20 Cytomegalovirus. 3.21 Dengue fever. 3.22 Diphtheria. 3.23 Encephalitis, acute. 3.24 Enterococci, including glycopeptide-resistant enterococci(GRE). 3.25 Epstein Barr virus. 3.26 Escherichia coli O157 (and other E. coligastroenteritis). 3.27 Giardiasis. 3.28 Gonorrhoea, syphilis and other acute STIs. 3.29 Hantavirus. 3.30 Head lice. 3.31 Helicobacter pylori. 3.32 Hepatitis A. 3.33 Hepatitis B. 3.34 Hepatitis C. 3.35 Delta hepatitis. 3.36 Hepatitis E. 3.37 Herpes simplex. 3.38 Haemophilus influenzae type b (Hib). 3.39 HIV. 3.40 Influenza. 3.41 Japanese B encephalitis. 3.42 Kawasaki Syndrome. 3.43 Legionellosis. 3.44 Leprosy. 3.45 Leptospirosis. 3.46 Listeria. 3.47 Lyme disease. 3.48 Malaria. 3.49 Measles. 3.50 Meningococcal infection. 3.51 Molluscum contagiosum. 3.52 MRSA (methicillin-resistant Staphylococcus aureus). 3.53 Mumps. 3.54 Mycoplasma. 3.55 Norovirus. 3.56 Paratyphoid fever. 3.57 Parvovirus B19 (fifth disease). 3.58 Plague. 3.59 Pneumococcal infection. 3.60 Poliomyelitis. 3.61 Q fever. 3.62 Rabies. 3.63 Relapsing Fever. 3.64 Respiratory syncytial virus (RSV). 3.65 Ringworm. 3.66 Rotavirus. 3.67 Rubella. 3.68 Salmonellosis. 3.69 Severe Acute Respiratory Syndrome (SARS). 3.70 Scabies 3.71 Shigella. 3.72 Smallpox. 3.73 Staphylococcal food poisoning. 3.74 Streptococcal infections. 3.75 Tetanus. 3.76 Threadworms. 3.77 Tick-borne encephalitis. 3.78 Toxocara. 3.79 Toxoplasmosis. 3.80 Tuberculosis. 3.81 Tularaemia. 3.82 Typhoid fever. 3.83 Rickettsial infections (incl. Typhus) Ehrlichia andBartonella. 3.84 Vibrio parahaemolyticus. 3.85 Viral haemorrhagic fevers. 3.86 Warts and verrucae. 3.87 West Nile Virus. 3.88 Whooping cough. 3.89 Yellow fever. 3.90 Yersiniosis. 3.91 Other organisms. Section 4: Services and organisations. 4.1 Surveillance of communicable disease. 4.2 Managing infectious disease incidents and outbreaks. 4.3 Infection Prevention and Control in the Community. 4.4 Healthcare Associated Infection. 4.5 Antimicrobial Resistance. 4.6 Risks to and from Health Care Workers. 4.7 Co-ordination of immunisation services. 4.8 Services for sexual health and HIV infection. 4.9 Services for tuberculosis control. 4.10 Travel Health. 4.11 Pandemic Preparedness and the Influenza A H1N1 2009Pandemic. 4.12 Non-infectious environmental hazards. 4.13 Managing acute chemical incidents. 4.14 Managing acute radiation incidents. 4.15 Deliberate release of biological, chemical or radiologicalagents. 4.16 Media Relations and Crisis Communication. 4.17 Clinical Governance and Audit. 4.18 Global health. Section 5: Communicable disease control in Europe. 5.1 WHO and International Health Regulations (IHR). 5.2 Collaboration within the European Union. 5.3 Detailed national example: organisational arrangements forhealth protection: England, 2010. 5.4 Austria. 5.5 Belgium. 5.6 Bulgaria. 5.7 Cyprus. 5.8 Czech Republic. 5.9 Denmark. 5.10 Estonia. 5.11 Finland. 5.12 France. 5.13 Germany. 5.14 Greece. 5.15 Hungary. 5.16 Iceland. 5.17 Ireland. 5.18 Italy. 5.19 Latvia. 5.20 Lithuania. 5.21 Luxembourg. 5.22 Malta. 5.23 The Netherlands. 5.24 Norway. 5.25 Poland. 5.26 Portugal. 5.27 Romania. 5.28 Slovakia. 5.29 Slovenia. 5.30 Spain. 5.31 Sweden. 5.32 Switzerland. 5.33 United Kingdom. Appendix 1 Useful addresses and telephone numbers. Appendix 2 Guidance documents and books. Index.
Note 400 annual accesses. UkHlHU
ISBN 9781444346930 (e-book)
9781444335675 (pbk.)
9781444346930 (PDF e-book)
9781444346961 (HTML e-book)
9781444346947 (ePub e-book)
9781444346954 (Mobipocket e-book)
Click on the terms below to find similar items in the catalogue
Subject Communicable diseases.
Communicable diseases -- Prevention.
Alt author Hawker, Jeremy.
Related title Communicable disease control handbook.
Descript xiii, 440 p. : col. ill.
Edition 3rd ed.
Note Previous ed.: published as Communicable disease control handbook. Blackwell Science, 2005.
Contents Foreword. Abbreviations. Section 1: Introduction. 1.1 How to use this book. 1.2 Basic Concepts in the Epidemiology and Control of InfectiousDisease. 1.3 Health Protection on-call. Section 2: Common topics. 2.1 Meningitis and meningism. 2.2 Gastrointestinal infection. 2.3 Community acquired pneumonia. 2.4 Rash in pregnancy. 2.5 Rash and fever in children. 2.6 Illness in returning travellers. 2.7 Sexually Transmitted Infections. 2.8 Jaundice. 2.9 Infection in the immunocompromised. 2.10 Blood borne viral infections. 2.11 Vaccine Queries. 2.12 Individual measures against infections. Section 3: Diseases. 3.1 Amoebic dysentery. 3.2 Anthrax. 3.3 Bacillus cereus. 3.4 Botulism. 3.5 Brucellosis. 3.6 Burkholderia. 3.7 Campylobacter. 3.8 Chickenpox and shingles (varicella-zoster infections). 3.9 Chikungunya. 3.10 Chlamydophila pneumoniae. 3.11 Chlamydophila psittaci. 3.12 Chlamydia trachomatis (genital). 3.13 Cholera. 3.14 CJD and other human transmissible spongiformencephalopathies. 3.15 Clostridium difficile. 3.16 Clostridium perfringens. 3.17 Coxsackievirus infections. 3.18 Cryptosporidiosis. 3.19 Cyclosporiasis. 3.20 Cytomegalovirus. 3.21 Dengue fever. 3.22 Diphtheria. 3.23 Encephalitis, acute. 3.24 Enterococci, including glycopeptide-resistant enterococci(GRE). 3.25 Epstein Barr virus. 3.26 Escherichia coli O157 (and other E. coligastroenteritis). 3.27 Giardiasis. 3.28 Gonorrhoea, syphilis and other acute STIs. 3.29 Hantavirus. 3.30 Head lice. 3.31 Helicobacter pylori. 3.32 Hepatitis A. 3.33 Hepatitis B. 3.34 Hepatitis C. 3.35 Delta hepatitis. 3.36 Hepatitis E. 3.37 Herpes simplex. 3.38 Haemophilus influenzae type b (Hib). 3.39 HIV. 3.40 Influenza. 3.41 Japanese B encephalitis. 3.42 Kawasaki Syndrome. 3.43 Legionellosis. 3.44 Leprosy. 3.45 Leptospirosis. 3.46 Listeria. 3.47 Lyme disease. 3.48 Malaria. 3.49 Measles. 3.50 Meningococcal infection. 3.51 Molluscum contagiosum. 3.52 MRSA (methicillin-resistant Staphylococcus aureus). 3.53 Mumps. 3.54 Mycoplasma. 3.55 Norovirus. 3.56 Paratyphoid fever. 3.57 Parvovirus B19 (fifth disease). 3.58 Plague. 3.59 Pneumococcal infection. 3.60 Poliomyelitis. 3.61 Q fever. 3.62 Rabies. 3.63 Relapsing Fever. 3.64 Respiratory syncytial virus (RSV). 3.65 Ringworm. 3.66 Rotavirus. 3.67 Rubella. 3.68 Salmonellosis. 3.69 Severe Acute Respiratory Syndrome (SARS). 3.70 Scabies 3.71 Shigella. 3.72 Smallpox. 3.73 Staphylococcal food poisoning. 3.74 Streptococcal infections. 3.75 Tetanus. 3.76 Threadworms. 3.77 Tick-borne encephalitis. 3.78 Toxocara. 3.79 Toxoplasmosis. 3.80 Tuberculosis. 3.81 Tularaemia. 3.82 Typhoid fever. 3.83 Rickettsial infections (incl. Typhus) Ehrlichia andBartonella. 3.84 Vibrio parahaemolyticus. 3.85 Viral haemorrhagic fevers. 3.86 Warts and verrucae. 3.87 West Nile Virus. 3.88 Whooping cough. 3.89 Yellow fever. 3.90 Yersiniosis. 3.91 Other organisms. Section 4: Services and organisations. 4.1 Surveillance of communicable disease. 4.2 Managing infectious disease incidents and outbreaks. 4.3 Infection Prevention and Control in the Community. 4.4 Healthcare Associated Infection. 4.5 Antimicrobial Resistance. 4.6 Risks to and from Health Care Workers. 4.7 Co-ordination of immunisation services. 4.8 Services for sexual health and HIV infection. 4.9 Services for tuberculosis control. 4.10 Travel Health. 4.11 Pandemic Preparedness and the Influenza A H1N1 2009Pandemic. 4.12 Non-infectious environmental hazards. 4.13 Managing acute chemical incidents. 4.14 Managing acute radiation incidents. 4.15 Deliberate release of biological, chemical or radiologicalagents. 4.16 Media Relations and Crisis Communication. 4.17 Clinical Governance and Audit. 4.18 Global health. Section 5: Communicable disease control in Europe. 5.1 WHO and International Health Regulations (IHR). 5.2 Collaboration within the European Union. 5.3 Detailed national example: organisational arrangements forhealth protection: England, 2010. 5.4 Austria. 5.5 Belgium. 5.6 Bulgaria. 5.7 Cyprus. 5.8 Czech Republic. 5.9 Denmark. 5.10 Estonia. 5.11 Finland. 5.12 France. 5.13 Germany. 5.14 Greece. 5.15 Hungary. 5.16 Iceland. 5.17 Ireland. 5.18 Italy. 5.19 Latvia. 5.20 Lithuania. 5.21 Luxembourg. 5.22 Malta. 5.23 The Netherlands. 5.24 Norway. 5.25 Poland. 5.26 Portugal. 5.27 Romania. 5.28 Slovakia. 5.29 Slovenia. 5.30 Spain. 5.31 Sweden. 5.32 Switzerland. 5.33 United Kingdom. Appendix 1 Useful addresses and telephone numbers. Appendix 2 Guidance documents and books. Index.
Note 400 annual accesses. UkHlHU
ISBN 9781444346930 (e-book)
9781444335675 (pbk.)
9781444346930 (PDF e-book)
9781444346961 (HTML e-book)
9781444346947 (ePub e-book)
9781444346954 (Mobipocket e-book)
Subject Communicable diseases.
Communicable diseases -- Prevention.
Alt author Hawker, Jeremy.
Related title Communicable disease control handbook.

Subject Communicable diseases.
Communicable diseases -- Prevention.
Descript xiii, 440 p. : col. ill.
Note Previous ed.: published as Communicable disease control handbook. Blackwell Science, 2005.
Contents Foreword. Abbreviations. Section 1: Introduction. 1.1 How to use this book. 1.2 Basic Concepts in the Epidemiology and Control of InfectiousDisease. 1.3 Health Protection on-call. Section 2: Common topics. 2.1 Meningitis and meningism. 2.2 Gastrointestinal infection. 2.3 Community acquired pneumonia. 2.4 Rash in pregnancy. 2.5 Rash and fever in children. 2.6 Illness in returning travellers. 2.7 Sexually Transmitted Infections. 2.8 Jaundice. 2.9 Infection in the immunocompromised. 2.10 Blood borne viral infections. 2.11 Vaccine Queries. 2.12 Individual measures against infections. Section 3: Diseases. 3.1 Amoebic dysentery. 3.2 Anthrax. 3.3 Bacillus cereus. 3.4 Botulism. 3.5 Brucellosis. 3.6 Burkholderia. 3.7 Campylobacter. 3.8 Chickenpox and shingles (varicella-zoster infections). 3.9 Chikungunya. 3.10 Chlamydophila pneumoniae. 3.11 Chlamydophila psittaci. 3.12 Chlamydia trachomatis (genital). 3.13 Cholera. 3.14 CJD and other human transmissible spongiformencephalopathies. 3.15 Clostridium difficile. 3.16 Clostridium perfringens. 3.17 Coxsackievirus infections. 3.18 Cryptosporidiosis. 3.19 Cyclosporiasis. 3.20 Cytomegalovirus. 3.21 Dengue fever. 3.22 Diphtheria. 3.23 Encephalitis, acute. 3.24 Enterococci, including glycopeptide-resistant enterococci(GRE). 3.25 Epstein Barr virus. 3.26 Escherichia coli O157 (and other E. coligastroenteritis). 3.27 Giardiasis. 3.28 Gonorrhoea, syphilis and other acute STIs. 3.29 Hantavirus. 3.30 Head lice. 3.31 Helicobacter pylori. 3.32 Hepatitis A. 3.33 Hepatitis B. 3.34 Hepatitis C. 3.35 Delta hepatitis. 3.36 Hepatitis E. 3.37 Herpes simplex. 3.38 Haemophilus influenzae type b (Hib). 3.39 HIV. 3.40 Influenza. 3.41 Japanese B encephalitis. 3.42 Kawasaki Syndrome. 3.43 Legionellosis. 3.44 Leprosy. 3.45 Leptospirosis. 3.46 Listeria. 3.47 Lyme disease. 3.48 Malaria. 3.49 Measles. 3.50 Meningococcal infection. 3.51 Molluscum contagiosum. 3.52 MRSA (methicillin-resistant Staphylococcus aureus). 3.53 Mumps. 3.54 Mycoplasma. 3.55 Norovirus. 3.56 Paratyphoid fever. 3.57 Parvovirus B19 (fifth disease). 3.58 Plague. 3.59 Pneumococcal infection. 3.60 Poliomyelitis. 3.61 Q fever. 3.62 Rabies. 3.63 Relapsing Fever. 3.64 Respiratory syncytial virus (RSV). 3.65 Ringworm. 3.66 Rotavirus. 3.67 Rubella. 3.68 Salmonellosis. 3.69 Severe Acute Respiratory Syndrome (SARS). 3.70 Scabies 3.71 Shigella. 3.72 Smallpox. 3.73 Staphylococcal food poisoning. 3.74 Streptococcal infections. 3.75 Tetanus. 3.76 Threadworms. 3.77 Tick-borne encephalitis. 3.78 Toxocara. 3.79 Toxoplasmosis. 3.80 Tuberculosis. 3.81 Tularaemia. 3.82 Typhoid fever. 3.83 Rickettsial infections (incl. Typhus) Ehrlichia andBartonella. 3.84 Vibrio parahaemolyticus. 3.85 Viral haemorrhagic fevers. 3.86 Warts and verrucae. 3.87 West Nile Virus. 3.88 Whooping cough. 3.89 Yellow fever. 3.90 Yersiniosis. 3.91 Other organisms. Section 4: Services and organisations. 4.1 Surveillance of communicable disease. 4.2 Managing infectious disease incidents and outbreaks. 4.3 Infection Prevention and Control in the Community. 4.4 Healthcare Associated Infection. 4.5 Antimicrobial Resistance. 4.6 Risks to and from Health Care Workers. 4.7 Co-ordination of immunisation services. 4.8 Services for sexual health and HIV infection. 4.9 Services for tuberculosis control. 4.10 Travel Health. 4.11 Pandemic Preparedness and the Influenza A H1N1 2009Pandemic. 4.12 Non-infectious environmental hazards. 4.13 Managing acute chemical incidents. 4.14 Managing acute radiation incidents. 4.15 Deliberate release of biological, chemical or radiologicalagents. 4.16 Media Relations and Crisis Communication. 4.17 Clinical Governance and Audit. 4.18 Global health. Section 5: Communicable disease control in Europe. 5.1 WHO and International Health Regulations (IHR). 5.2 Collaboration within the European Union. 5.3 Detailed national example: organisational arrangements forhealth protection: England, 2010. 5.4 Austria. 5.5 Belgium. 5.6 Bulgaria. 5.7 Cyprus. 5.8 Czech Republic. 5.9 Denmark. 5.10 Estonia. 5.11 Finland. 5.12 France. 5.13 Germany. 5.14 Greece. 5.15 Hungary. 5.16 Iceland. 5.17 Ireland. 5.18 Italy. 5.19 Latvia. 5.20 Lithuania. 5.21 Luxembourg. 5.22 Malta. 5.23 The Netherlands. 5.24 Norway. 5.25 Poland. 5.26 Portugal. 5.27 Romania. 5.28 Slovakia. 5.29 Slovenia. 5.30 Spain. 5.31 Sweden. 5.32 Switzerland. 5.33 United Kingdom. Appendix 1 Useful addresses and telephone numbers. Appendix 2 Guidance documents and books. Index.
Note 400 annual accesses. UkHlHU
Alt author Hawker, Jeremy.
ISBN 9781444346930 (e-book)
9781444335675 (pbk.)
9781444346930 (PDF e-book)
9781444346961 (HTML e-book)
9781444346947 (ePub e-book)
9781444346954 (Mobipocket e-book)

Links and services for this item: